Cargando…
A rare case of DIC in a patient with Wilson’s disease: D-penicillamine
D-penicillamine therapy is considered an effective and safe treatment for Wilson’s disease. Except for one experimental study, there has been no report in the literature about the development of disseminated intravascular coagulation (DIC) with the use of the drug. A 24-year-old female patient with...
Autores principales: | Emre Parlar, Yavuz, Yasemin Balaban, Hatice, Yavuz Malkan, Umit, Deniz, Erdogan, Rukiye Uysal, Fatma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243762/ https://www.ncbi.nlm.nih.gov/pubmed/35783473 http://dx.doi.org/10.14744/hf.2022.2022.0001 |
Ejemplares similares
-
Liver immunity, autoimmunity, and inborn errors of immunity
por: Parlar, Yavuz Emre, et al.
Publicado: (2023) -
D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
por: Goh, Yihui, et al.
Publicado: (2021) -
D-penicillamine Induced Myasthenia Gravis in Wilson’s Disease: A Case Report
por: Thapa, Lekhjung, et al.
Publicado: (2022) -
Evaluation of vitamin B(6) supplementation in Wilson’s disease patients treated with D-penicillamine
por: Mbala, Justin, et al.
Publicado: (2023) -
Pompholyx-Like Eruptions Induced by Penicillamine in a Patient with Wilson's Disease
por: Devassy, Diana Elizabeth, et al.
Publicado: (2019)